Actively Recruiting
Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation
Led by University of Iowa · Updated on 2025-08-24
56
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The increase in skin blood flow in response to rapid local heating of the skin (i.e., cutaneous vasodilation) is commonly used to assess nitric oxide (NO)-dependent dilation and overall microvascular function. Historically, rapid local heating to 42°C was considered the standard approach for these assessments. More recently, many investigators have adopted rapid local to 39°C instead, based on its larger dependency on NO and therefore improved ability to quantify NO-dependent dilation without the use of pharmacological techniques. However, to date, only one direct methodological comparison between these protocols has been performed. In this study, the investigators use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) they examine the blood vessels in a nickel-sized area of the skin in young adults ages 18 - 30 years old. Local heating of the skin at the microdialysis sites is used to explore differences in mechanisms governing microvascular control. As a compliment to these measurements, the investigators also have participants fill out a variety of surveys to assess things such as sleep quality, physical activity, daily stressors, etc.
CONDITIONS
Official Title
Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women
- Between 18 and 30 years of age
You will not qualify if you...
- Current or recent (within 8 weeks) use of medications that could affect microvascular function, including stimulants, antihypertensives, or cholesterol-lowering drugs
- Changes in medication status, such as starting a new medication or changing doses
- Unstable or diagnosed chronic diseases, including cardiovascular, metabolic, kidney, liver, autonomic, autoimmune, or skin diseases like hypertension, heart disease, diabetes, hyperlipidemia, or psoriasis
- Body mass index below 18.5 or above 35 kg/m2
- Pregnancy or breastfeeding
- Known allergies to study drugs or pharmacological agents
- Not able to understand English well enough to follow study procedures and instructions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Iowa
Iowa City, Iowa, United States, 52242
Actively Recruiting
Research Team
A
Anna Stanhewicz, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here